Skip to main content
. 2021 Dec 23;12:794640. doi: 10.3389/fneur.2021.794640

Table 2.

Gastrointestinal symptoms at baseline and after a 5-week Mediterranean diet interventiona.

GSRS syndrome scoresb Parkinson's disease (n = 8) P-value
Baseline Intervention
Abdominal pain syndrome 1.52 ± 0.32 1.13 ± 0.06 0.13c
Diarrhea syndrome 1.10 ± 0.08 1.04 ± 0.04 1.00c
Constipation syndrome 2.25 ± 0.48 1.54 ± 0.31 0.04*
Indigestion syndrome 1.69 ± 0.21 1.41 ± 0.15 0.02*
Reflux syndrome 1.31 ± 0.25 1.06 ± 0.06 0.50c
a

GSRS, Gastrointestinal Symptom Rating Scale. Baseline vs. Intervention for the PD group was also compared using a paired t-test, unless otherwise indicated.

*

P < 0.05.

b

Symptoms for each syndrome are scored on a rating scale of 1 = no discomfort at all to 7 = very severe discomfort. Abdominal pain symptoms included abdominal pain, hunger pains, and nausea. Diarrhea symptoms included diarrhea, loose stools, and urgent need to defecate. Constipation symptoms included constipation, hard stools, and feeling of incomplete evacuation. Indigestion symptoms included rumbling, bloating, burping and gas. Reflux symptoms included heartburn and acid regurgitation.

c

Compared using the non-parametric Wilcoxon Signed-Rank test.

Bolded values indicate significance.